Annual Cash & Cash Equivalents
$60.65 M
-$27.56 M-31.24%
December 31, 2022
Summary
- As of February 9, 2025, IMPL annual cash & cash equivalents is $60.65 million, with the most recent change of -$27.56 million (-31.24%) on December 31, 2022.
- During the last 3 years, IMPL annual cash & cash equivalents has risen by +$23.65 million (+63.93%).
Performance
IMPL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$239.00 K
-$14.92 M-98.42%
September 1, 2023
Summary
- As of February 9, 2025, IMPL quarterly cash and cash equivalents is $239.00 thousand, with the most recent change of -$14.92 million (-98.42%) on September 1, 2023.
- Over the past year, IMPL quarterly cash and cash equivalents has dropped by -$79.49 million (-99.70%).
Performance
IMPL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IMPL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.2% | -99.7% |
| 3 y3 years | +63.9% | - |
| 5 y5 years | +63.9% | - |
IMPL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.2% | at low | -99.8% | at low |
| 5 y | 5-year | -31.2% | -88.3% | -99.8% | at low |
| alltime | all time | -31.2% | -88.3% | -99.8% | at low |
Impel Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $239.00 K(-98.4%) |
| Jun 2023 | - | $15.16 M(-57.2%) |
| Mar 2023 | - | $35.47 M(-41.5%) |
| Dec 2022 | $60.65 M | $60.65 M(-23.9%) |
| Sep 2022 | - | $79.73 M(-18.5%) |
| Jun 2022 | - | $97.83 M(-24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $129.84 M(+47.2%) |
| Dec 2021 | $88.21 M(+1143.3%) | $88.21 M(-20.7%) |
| Sep 2021 | - | $111.29 M(+82.6%) |
| Jun 2021 | - | $60.95 M(+1264.4%) |
| Mar 2021 | - | $4.47 M(-37.0%) |
| Dec 2020 | $7.09 M(-80.8%) | $7.09 M |
| Dec 2019 | $37.00 M | - |
FAQ
- What is Impel Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Impel Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Impel Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of IMPL is $60.65 M
What is the all time high annual cash & cash equivalents for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high annual cash & cash equivalents is $88.21 M
What is Impel Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, IMPL annual cash & cash equivalents has changed by -$27.56 M (-31.24%)
What is Impel Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IMPL is $239.00 K
What is the all time high quarterly cash and cash equivalents for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high quarterly cash and cash equivalents is $129.84 M
What is Impel Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, IMPL quarterly cash and cash equivalents has changed by -$79.49 M (-99.70%)